Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorSCHILD, Raphael
dc.contributor.authorDUPONT, Simeon
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorHARAMBAT, Jerome
IDREF: 110567358
dc.contributor.authorVIDAL, Enrico
dc.contributor.authorBALAT, Ayse
dc.contributor.authorBERECZKI, Csaba
dc.contributor.authorBIENIAS, Beata
dc.contributor.authorBRANDSTROM, Per
dc.contributor.authorBROUX, Francoise
dc.contributor.authorCONSOLO, Silvia
dc.contributor.authorGOJKOVIC, Ivana
dc.contributor.authorGROOTHOFF, Jaap W.
dc.contributor.authorHOMMEL, Kristine
dc.contributor.authorHUBMANN, Holger
dc.contributor.authorBRADDON, Fiona E. M.
dc.contributor.authorPANKRATENKO, Tatiana E.
dc.contributor.authorPAPACHRISTOU, Fotios
dc.contributor.authorPLUMB, Lucy A.
dc.contributor.authorPODRACKA, Ludmila
dc.contributor.authorPROKURAT, Sylwester
dc.contributor.authorBJERRE, Anna
dc.contributor.authorCORDINHA, Carolina
dc.contributor.authorTAINIO, Juuso
dc.contributor.authorSHKURTI, Enkelejda
dc.contributor.authorSPARTA, Giuseppina
dc.contributor.authorVONDRAK, Karel
dc.contributor.authorJAGER, Kitty J.
dc.contributor.authorOH, Jun
dc.contributor.authorBONTHUIS, Marjolein
dc.date.accessioned2023-05-15T12:10:39Z
dc.date.available2023-05-15T12:10:39Z
dc.date.issued2023-04
dc.identifier.issn2048-8505 (Print) 2048-8513 (Electronic)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/182137
dc.description.abstractEnBACKGROUND: Data on comorbidities in children on kidney replacement therapy (KRT) are scarce. Considering their high relevance for prognosis and treatment, this study aims to analyse the prevalence and implications of comorbidities in European children on KRT. METHODS: We included data from patients <20 years of age when commencing KRT from 2007 to 2017 from 22 European countries within the European Society of Paediatric Nephrology/European Renal Association Registry. Differences between patients with and without comorbidities in access to kidney transplantation (KT) and patient and graft survival were estimated using Cox regression. RESULTS: Comorbidities were present in 33% of the 4127 children commencing KRT and the prevalence has steadily increased by 5% annually since 2007. Comorbidities were most frequent in high-income countries (43% versus 24% in low-income countries and 33% in middle-income countries). Patients with comorbidities had a lower access to transplantation adjusted hazard ratio [aHR] 0.67 [95% confidence interval (CI) 0.61-0.74] and a higher risk of death [aHR 1.79 (95% CI 1.38-2.32)]. The increased mortality was only seen in dialysis patients [aHR 1.60 (95% CI 1.21-2.13)], and not after KT. For both outcomes, the impact of comorbidities was stronger in low-income countries. Graft survival was not affected by the presence of comorbidities [aHR for 5-year graft failure 1.18 (95% CI 0.84-1.65)]. CONCLUSIONS: Comorbidities have become more frequent in children on KRT and reduce their access to transplantation and survival, especially when remaining on dialysis. KT should be considered as an option in all paediatric KRT patients and efforts should be made to identify modifiable barriers to KT for children with comorbidities.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/us/*
dc.subject.enChildren
dc.subject.enChronic kidney disease
dc.subject.enComorbidities
dc.subject.enEpidemiology
dc.subject.enKidney transplantation
dc.title.enDisparities in treatment and outcome of kidney replacement therapy in children with comorbidities: an ESPN/ERA Registry study
dc.title.alternativeClin Kidney Jen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1093/ckj/sfad008en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed37007701en_US
bordeaux.journalClinical Kidney Journalen_US
bordeaux.page745-755en_US
bordeaux.volume16en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue4en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamLEHA_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-04097668
hal.version1
hal.date.transferred2023-05-15T12:11:06Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=Clinical%20Kidney%20Journal&amp;rft.date=2023-04&amp;rft.volume=16&amp;rft.issue=4&amp;rft.spage=745-755&amp;rft.epage=745-755&amp;rft.eissn=2048-8505%20(Print)%202048-8513%20(Electronic)&amp;rft.issn=2048-8505%20(Print)%202048-8513%20(Electronic)&amp;rft.au=SCHILD,%20Raphael&amp;DUPONT,%20Simeon&amp;HARAMBAT,%20Jerome&amp;VIDAL,%20Enrico&amp;BALAT,%20Ayse&amp;rft.genre=article


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record